| Baseline | 30-day mortality | 6-month mortality | |||||
---|---|---|---|---|---|---|---|---|
Survivors | Nonsurvivors | Pvalue | Survivors | Nonsurvivors | Pvalue | |||
Strain analysis | ||||||||
RV free wall strain | RV dysfunction | 43/60 (72%) | Â | Â | 0.33 | Â | Â | 0.001 |
• < −21 | 17 | 13 | 4 | 12 | 5 | |||
• –13 to −21 | 31 | 21 | 10 | 18 | 13 | |||
• > −13 | 12 | 6 | 6 | 1 | 11 | |||
GLS | LV dysfunction | 36/52 (69%) | Â | Â | 0.40 | Â | Â | 0.44 |
• < −17 | 16 | 9 | 7 | 7 | 9 | |||
• –10 to −17 | 25 | 19 | 6 | 16 | 9 | |||
• > −10 | 11 | 8 | 3 | 6 | 5 | |||
Standard echocardiographic analysis | ||||||||
RV dysfunction | 19/60 (32%) | Â | Â | 0.26 | Â | Â | 0.17 | |
 Mild | 12 | 6 | 6 | 3 | 9 | |||
 Moderate | 4 | 3 | 1 | 3 | 1 | |||
 Severe | 3 | 3 | 0 | 2 | 1 | |||
LV dysfunction | 20/60 (33%) | Â | Â | 0.50 | Â | Â | 0.55 | |
 Mild (EF = 45 to 55%) | 8 | 5 | 3 | 4 | 4 | |||
 Moderate (EF = 35 to 45%) | 8 | 7 | 1 | 6 | 2 | |||
 Severe (EF < 35%) | 4 | 3 | 1 | 2 | 2 |